| Intracranial Aneurysms: Treatment and Complications | Lifetime | 6 | US 5 | 99.88 |
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 8 | US 5 | 99.86 |
| Traumatic Brain Injury and Neurovascular Disturbances | Lifetime | 24 | US 13 | 99.86 |
| Neurosurgical Procedures and Complications | Lifetime | 19 | US 12 | 99.63 |
| Anesthesia and Neurotoxicity Research | Lifetime | 40 | US 27 | 99.51 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 64 | US 29 | 99.65 |
| Acute Ischemic Stroke Management | Lifetime | 120 | US 52 | 99.56 |
| Hydrogen's biological and therapeutic effects | Lifetime | 7 | US 2 | 98.72 |
| Neonatal and fetal brain pathology | Lifetime | 69 | US 35 | 99.23 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 90 | US 36 | 99.11 |
| Diabetic Foot Ulcer Assessment and Management | Lifetime | 97 | US 46 | 98.71 |
| S100 Proteins and Annexins | Lifetime | 128 | US 69 | 98.36 |
| Reproductive Biology and Fertility | Lifetime | 392 | US 146 | 98.76 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 759 | US 368 | 98.14 |
| Immune cells in cancer | Lifetime | 382 | US 155 | 97.85 |
| Cerebrospinal fluid and hydrocephalus | Lifetime | 290 | US 146 | 97.55 |
| Barrier Structure and Function Studies | Lifetime | 113 | US 55 | 97.05 |
| Heme Oxygenase-1 and Carbon Monoxide | Lifetime | 263 | US 145 | 96.87 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 364 | US 119 | 96.57 |
| Prenatal Screening and Diagnostics | Lifetime | 550 | US 203 | 97.19 |
| Assisted Reproductive Technology and Twin Pregnancy | Lifetime | 580 | US 210 | 96.78 |
| Kruppel-like factors research | Lifetime | 251 | US 99 | 95.17 |
| Cerebrovascular and genetic disorders | Lifetime | 119 | US 31 | 95.40 |
| Vascular Malformations Diagnosis and Treatment | Lifetime | 621 | US 309 | 96.17 |
| Autophagy in Disease and Therapy | Lifetime | 941 | US 296 | 94.92 |
| Axon Guidance and Neuronal Signaling | Lifetime | 337 | US 161 | 95.44 |
| Cell death mechanisms and regulation | Lifetime | 979 | US 388 | 94.08 |
| Adenosine and Purinergic Signaling | Lifetime | 955 | US 326 | 92.82 |
| Bone and Dental Protein Studies | Lifetime | 747 | US 271 | 91.53 |
| Erythropoietin and Anemia Treatment | Lifetime | 759 | US 300 | 90.52 |
| Apelin-related biomedical research | Lifetime | 602 | US 178 | 88.12 |
| Spinal Hematomas and Complications | Lifetime | 500 | US 243 | 88.11 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 495 | US 161 | 83.24 |
| Bartonella species infections research | Lifetime | 378 | US 156 | 82.17 |
| Natural Compounds in Disease Treatment | Lifetime | 550 | US 65 | 72.09 |
| Intracerebral and Subarachnoid Hemorrhage Research | 2021-2025 | 26 | US 9 | 98.62 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 110 | US 37 | 97.38 |
| Intracranial Aneurysms: Treatment and Complications | 2021-2025 | 265 | US 120 | 94.62 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 120 | US 27 | 92.08 |
| Traumatic Brain Injury and Neurovascular Disturbances | 2021-2025 | 988 | US 366 | 89.23 |
| S100 Proteins and Annexins | 2021-2025 | 167 | US 35 | 83.23 |
| Neurosurgical Procedures and Complications | 2021-2025 | 672 | US 261 | 77.87 |
| Barrier Structure and Function Studies | 2021-2025 | 256 | US 81 | 72.87 |
| Heme Oxygenase-1 and Carbon Monoxide | 2021-2025 | 696 | US 118 | 64.41 |
| Eicosanoids and Hypertension Pharmacology | 2021-2025 | 886 | US 234 | 54.94 |
| Axon Guidance and Neuronal Signaling | 2021-2025 | 495 | US 162 | 43.46 |
| Apelin-related biomedical research | 2021-2025 | 635 | US 97 | 39.59 |
